128 results on '"McRonald, Fiona"'
Search Results
2. Second Primary Cancer Risks After Breast Cancer in BRCA1 and BRCA2 Pathogenic Variant Carriers
3. Risks of second primary cancers among 584,965 female and male breast cancer survivors in England: a 25-year retrospective cohort study
4. The comprehensive English National Lynch Syndrome Registry: development and description of a new genomics data resource
5. Sebaceous carcinoma epidemiology, associated malignancies and Lynch/Muir-Torre syndrome screening in England from 2008 to 2018
6. Lung adenocarcinoma promotion by air pollutants
7. Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysis
8. Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial
9. The comprehensive English National Lynch Syndrome Registry: development and description of a new genomics data resource
10. Recommendations for laboratory workflow that better support centralised amalgamation of genomic variant data: findings from CanVIG-UK national molecular laboratory survey
11. Identification and analysis of candidate genes in the Tylosis Oesophageal Cancer (TOC) minimal region on chromosome 17q25
12. Supplementary Figure from Cancer Prevention with Resistant Starch in Lynch Syndrome Patients in the CAPP2-Randomized Placebo Controlled Trial: Planned 10-Year Follow-up
13. Data from The UK Lung Screen (UKLS): Demographic Profile of First 88,897 Approaches Provides Recommendations for Population Screening
14. Data from Cancer Prevention with Resistant Starch in Lynch Syndrome Patients in the CAPP2-Randomized Placebo Controlled Trial: Planned 10-Year Follow-up
15. Supplementary Figures 1 - 2, Tables 1 - 3 from The UK Lung Screen (UKLS): Demographic Profile of First 88,897 Approaches Provides Recommendations for Population Screening
16. Germline mismatch repair (MMR) gene analyses from English NHS regional molecular genomics laboratories 1996–2020: development of a national resource of patient-level genomics laboratory records
17. Recommendations for laboratory workflow that better support centralised amalgamation of genomic variant data: findings from CanVIG-UK national molecular laboratory survey
18. Non-Small-Cell Lung Cancer Promotion by Air Pollutants
19. Germline mismatch repair (MMR) gene analyses from English NHS regional molecular genomics laboratories 1996-2020: development of a national resource of patient-level genomics laboratory records.
20. Cancer Prevention with Resistant Starch in Lynch Syndrome Patients in the CAPP2-Randomized Placebo Controlled Trial : Planned 10-Year Follow-up
21. Results from the randomised UKLS trial: Lung cancer mortality reduction by LDCT screening confirmed in an international meta-analysis
22. Harnessing national pan-laboratory data for accurate quantitation of PS4 in cancer susceptibility genes: Cancer Variant Interpretation Group UK (CanVIG-UK)
23. Novel microsatellite markers and single nucleotide polymorphisms refine the tylosis with oesophageal cancer (TOC) minimal region on 17q25 to 42.5 kb: sequencing does not identify the causative gene
24. The contribution of risk prediction models to early detection of lung cancer
25. Characterization of a 500 kb region on 17q25 and the exclusion of candidate genes as the familial Tylosis Oesophageal Cancer (TOC) locus
26. Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial
27. Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study : a double-blind, randomised, placebo-controlled trial
28. Re: Powers JM. p53-Mediated Apoptosis, Neuroglobin Overexpression, and Globin Deposits in a Patient with Hereditary Ferritinopathy. J Neuropathol Exp Neurol 2006;65:716-21
29. Frequent genetic and epigenetic abnormalities contribute to the deregulation of cytoglobin in non-small cell lung cancer
30. Down-regulation of the cytoglobin gene, located on 17q25, in tylosis with oesophageal cancer (TOC): evidence for trans-allele repression
31. Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study:a double-blind, randomised, placebo-controlled trial
32. Immunostaining of modified histones defines high-level features of the human metaphase epigenome
33. MOESM11 of Immunostaining of modified histones defines high-level features of the human metaphase epigenome
34. of Immunostaining of modified histones defines high-level features of the human metaphase epigenome
35. CpG methylation profiling in VHL related and VHL unrelated renal cell carcinoma
36. Anticipatory nausea in cyclical vomiting
37. Long-term psychosocial outcomes of low dose computed tomography screening: results of the UK Lung Cancer Screening (UKLS) randomised controlled trial
38. Long-term psychosocial outcomes of low-dose CT screening: results of the UK Lung Cancer Screening randomised controlled trial
39. The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer
40. RHBDF2 Mutations Are Associated with Tylosis, a Familial Esophageal Cancer Syndrome
41. Barriers to uptake among high-risk individuals declining participation in lung cancer screening: a mixed methods analysis of the UK Lung Cancer Screening (UKLS) trial
42. The UK Lung Screen (UKLS): Demographic Profile of First 88,897 Approaches Provides Recommendations for Population Screening
43. Abstract 3631: United Kingdom lung cancer screening trial (UKLS): First 88897 approaches.
44. Protection from Intracellular Oxidative Stress by Cytoglobin in Normal and Cancerous Oesophageal Cells
45. CpG methylation profiling in VHL related and VHL unrelated renal cell carcinoma
46. Anticipatory nausea in cyclical vomiting
47. Novel microsatellite markers and single nucleotide polymorphisms refine the tylosis with oesophageal cancer ( TOC ) minimal region on 17q25 to 42.5�kb: sequencing does not identify the causative gene
48. MOESM8 of Immunostaining of modified histones defines high-level features of the human metaphase epigenome
49. MOESM8 of Immunostaining of modified histones defines high-level features of the human metaphase epigenome
50. OP052 - Harnessing national pan-laboratory data for accurate quantitation of PS4 in cancer susceptibility genes: Cancer Variant Interpretation Group UK (CanVIG-UK).
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.